Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer.

@article{Shiraishi2010AssociationOD,
  title={Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer.},
  author={Kouya Shiraishi and Takashi Kohno and Chiharu Tanai and Yasushi Goto and Aya Kuchiba and Seiichiro Yamamoto and Koji Tsuta and Hiroshi Nokihara and Noboru Yamamoto and Ikuo Sekine and Yuichiro Ohe and Tomohide Tamura and Jun Yokota and Hideo Kunitoh},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2010},
  volume={28 33},
  pages={
          4945-52
        }
}
PURPOSE To identify polymorphisms in DNA repair genes that affect responses to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS In total, 640 patients with NSCLC who received platinum-based doublet chemotherapy in the National Cancer Center Hospital in Japan from 2000 to 2008 and whose responses were evaluated by Response Evaluation Criteria in Solid Tumors (RECIST) participated in a study of the association between response and… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 39 CITATIONS

A three-microRNA signature predicts responses to platinum-based doublet chemotherapy in patients with lung adenocarcinoma.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2014
VIEW 4 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 33 REFERENCES

First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review.

  • Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • 2010
VIEW 1 EXCERPT

Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel.

  • Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • 2009
VIEW 2 EXCERPTS

Silver DP: Synthetic lethality: A new direction in cancer-drug development

JD Iglehart
  • N Engl J Med
  • 2009

Similar Papers

Loading similar papers…